We are live on
!
Find out more
Axsome Therapeutics
AXSM
AXSM
174 hedge funds and large institutions have $791M invested in Axsome Therapeutics in 2022 Q1 according to their latest regulatory filings, with 31 funds opening new positions, 41 increasing their positions, 63 reducing their positions, and 22 closing their positions.
New
Increased
Maintained
Reduced
Closed
200% more funds holding in top 10
Funds holding in top 10: 1 → 3 (+2)
46% more call options, than puts
Call options by funds: $94.9M | Put options by funds: $64.8M
41% more first-time investments, than exits
New positions opened: 31 | Existing positions closed: 22
12% more capital invested
Capital invested by funds: $704M → $791M (+$87.5M)
4% more funds holding
Funds holding: 167 → 174 (+7)
0.23% more ownership
Funds ownership: 49.47% → 49.69% (+0.23%)
35% less repeat investments, than reductions
Existing positions increased: 41 | Existing positions reduced: 63
Holders
174
Holders Change
+7
Holders Change %
+4.19%
% of All Funds
2.74%
Holding in Top 10
3
Holding in Top 10 Change
+2
Holding in Top 10 Change %
+200%
% of All Funds
0.05%
New
31
Increased
41
Reduced
63
Closed
22
Calls
$94.9M
Puts
$64.8M
Net Calls
+$30.1M
Net Calls Change
-$60.5M
